Recognizing #BreastCancerAwarenessMonth this October. We honor all those who have been impacted by breast cancer and support all efforts to educate and spread awareness of this disease this month and beyond.
Our manuscript is out exploring real-world outcomes on PARPi in breast cancer. Patients with germline and somatic BRCA alterations have similar benefit (OS and PFS). A scar-based biomarker of HRD (HRDsig) is associated with favorable outcomes. https://t.co/CViUReG3vb
Pan-Cancer Analysis of Copy-Number Features Identifies Recurrent Signatures and a Homologous Recombination Deficiency Biomarker to Predict Poly (ADP-Ribose) Polymerase Inhibitor Response https://t.co/i0a2cAiT0U
I'm part of a small group that run a very successful podcast and have been going for a number of years. Truth is, I hate the subject we talk about now, but feel stuck due to the income.